ZIP6, the first LIV-1 family member to be described, is associated with ER (oestrogen receptor)-positive breast cancer [9], lymph node spread [10] and is a marker of ER-positive (Luminal A) cancers [11,12]. Here, SLC39A6 is linked to breast cancer.